40.75MMarket Cap-1039P/E (TTM)
3.1000High2.7100Low120.12KVolume2.7400Open2.7100Pre Close352.43KTurnover1.27%Turnover RatioLossP/E (Static)14.10MShares7.725052wk High0.46P/B27.31MFloat Cap1.670052wk Low--Dividend TTM9.45MShs Float2869.9200Historical High--Div YieldTTM14.39%Amplitude1.6700Historical Low2.9330Avg Price1Lot Size
VYNE Therapeutics Stock Forum
Vyne Therapeutics Announces FDA Clearance of Ind Application for Vyn202, a Novel Bd2-Selective Bet Inhibitor
NEWS
VYNE Therapeutics Announces FDA Clearance of IND Application for VYN202, a Novel BD2-Selective BET Inhibitor
GlobeNewswire· 5 mins ago
Dow Jones· 5 mins ago
No comment yet